Hsbc Holdings PLC 4 D Molecular Therapeutics, Inc. Transaction History
Hsbc Holdings PLC
- $168 Billion
- Q4 2024
A detailed history of Hsbc Holdings PLC transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 34,413 shares of FDMT stock, worth $159,676. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,413
Previous 18,271
88.35%
Holding current value
$159,676
Previous $197,000
3.05%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding FDMT
# of Institutions
147Shares Held
46.7MCall Options Held
121KPut Options Held
33.2K-
Black Rock Inc. New York, NY4.9MShares$22.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.56MShares$21.2 Million0.41% of portfolio
-
Goldman Sachs Group Inc New York, NY4.27MShares$19.8 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.95MShares$13.7 Million2.71% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.86MShares$13.3 Million0.0% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $150M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...